Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.
Saved in:
| Title: | Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity. |
|---|---|
| Authors: | Zhang Y; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China., Feng Y; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Medical Science Laboratory, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China., Huang Y; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China., Wang Y; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China., Qiu L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China., Liu Y; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China., Peng S; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China., Li R; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China., Kuang N; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China., Shi Q; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China., Shi Y; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China., Chen Y; Medical Laboratory, Jiangxi Provincial People's Hospital, Nanchang, China., Joshi R; Department of Surgery, Pathology and Oncology, University of Western Ontario, London, ON, Canada., Wang Z; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China., Yuan K; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China., Min W; Institute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.; Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China.; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.; Department of Surgery, Pathology and Oncology, University of Western Ontario, London, ON, Canada. |
| Source: | Frontiers in immunology [Front Immunol] 2020 Jun 09; Vol. 11, pp. 968. Date of Electronic Publication: 2020 Jun 09 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2020.00968 |
